Purolite, the faction of Ecolab that deals with resin, together with Repligen Corporation, a bioprocessing technology specialist, has commercially launched Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes.
This new affinity resin is being introduced at the BIO International Convention (BIO 2024), being held June 3-6 in San Diego.
This latest innovation marks a significant milestone in Purolite’s long-term strategic partnership with Repligen, further solidifying Ecolab’s dedication to driving advancements in the bioprocessing industry.
Boosting commercial monoclonal antibody manufacturing
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies, where cost of goods is critical for biologic drug developers.
Senior Vice President and general manager at Purolite, Srini Paluri stated, “This new resin enables biologic developers to increase manufacturing efficiencies, reduce their cost of goods, and accelerate the delivery of innovation to the clinic.”
Visitors to BIO International can find Purolite and the team in Hall F at booth 4649, where they can learn more.
[Photo credit: Kailas Disale]
